| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 99.20% | 92.61% | 99.10% | 99.17% | 98.05% | 98.70% |
| Debt | 5.90% | 7.67% | 7.95% | 7.21% | 3.78% | 5.39% |
| Others (incl. cash) | -5.09% | -0.28% | -7.04% | -6.38% | -1.83% | -4.09% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 3,53,358 | 70.34 | 8.53% | 0.42%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 1,25,810 | 64.45 | 7.81% | - |
| Laurus Labs Ltd. | Healthcare | 2,24,371 | 40.75 | 4.94% | 0.63%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 44,041 | 39.45 | 4.78% | 0.49%↑ |
| Divis Laboratories Ltd. | Healthcare | 39,553 | 31.86 | 3.86% | 2.29%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 2,82,001 | 30.98 | 3.76% | -0.26%↓ |
| Cipla Ltd. | Healthcare | 2,08,361 | 30.7 | 3.72% | 0.69%↑ |
| Sai Life Sciences Ltd. | Healthcare | 1,99,300 | 26.21 | 3.18% | 0.17%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 2,15,085 | 24.24 | 2.94% | 0.87%↑ |
| Neuland Laboratories Ltd. | Healthcare | 12,431 | 23.67 | 2.87% | 0.56%↑ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1,09,504 | 20.86 | 2.53% | 0.72%↑ |
| CORONA Remedies Ltd. | Healthcare | 95,727 | 20.09 | 2.44% | 0.06%↑ |
| Aurobindo Pharma Ltd. | Healthcare | 1,26,332 | 19.96 | 2.42% | -0.10%↓ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 2,39,748 | 19.29 | 2.34% | -0.75%↓ |
| Fortis Healthcare Ltd. | Healthcare | 1,92,236 | 18.17 | 2.20% | -1.18%↓ |
| Thyrocare Technologies Ltd. | Healthcare | 3,12,786 | 18.11 | 2.20% | 0.23%↑ |
| Narayana Hrudayalaya Ltd. | Healthcare | 73,919 | 15 | 1.82% | 0.18%↑ |
| Ajanta Pharma Ltd. | Healthcare | 43,021 | 14.91 | 1.81% | 0.27%↑ |
| Procter & Gamble Health Ltd. | Healthcare | 21,176 | 13.99 | 1.70% | 0.47%↑ |
| Rainbow Childrens Medicare Ltd. | Healthcare | 87,173 | 13.3 | 1.61% | 0.25%↑ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 93.56% | 87.96% | 94.12% | 93.65% | 92.98% | 93.24% |
| Chemicals | 3.40% | 2.59% | 2.49% | 3.24% | 3.00% | 3.06% |
| Materials | 1.39% | 1.26% | 1.75% | 1.31% | 1.58% | 1.78% |
| Services | 0.85% | 0.80% | 0.74% | 0.96% | 0.48% | 0.61% |
21.9 / 100
Weighted average Value score is 21.9. This indicates that portfolio is relatively overvalued using composite of value measures.
68.6 / 100
Weighted average Price Momentum score is 68.6. This indicates that portfolio has average momentum using composite of momentum measures.
81.1 / 100
Weighted average Quality score is 81.1. This indicates that portfolio has high quality using composite of quality measures.
66.8 / 100
Weighted average QVM score is 66.8. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
